Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.
Schnur RC, Corman ML, Gallaschun RJ, Cooper BA, Dee MF, Doty JL, Muzzi ML, Moyer JD, DiOrio CI, Barbacci EG, et al. Schnur RC, et al. Among authors: barbacci eg. J Med Chem. 1995 Sep 15;38(19):3806-12. doi: 10.1021/jm00019a010. J Med Chem. 1995. PMID: 7562911
Binding of benzoquinoid ansamycins to p100 correlates with their ability to deplete the erbB2 gene product p185.
Miller P, Schnur RC, Barbacci E, Moyer MP, Moyer JD. Miller P, et al. Biochem Biophys Res Commun. 1994 Jun 30;201(3):1313-9. doi: 10.1006/bbrc.1994.1847. Biochem Biophys Res Commun. 1994. PMID: 7912926
The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells.
Barbacci EG, Pustilnik LR, Rossi AM, Emerson E, Miller PE, Boscoe BP, Cox ED, Iwata KK, Jani JP, Provoncha K, Kath JC, Liu Z, Moyer JD. Barbacci EG, et al. Cancer Res. 2003 Aug 1;63(15):4450-9. Cancer Res. 2003. PMID: 12907618 Free article.
Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice.
Pollack VA, Savage DM, Baker DA, Tsaparikos KE, Sloan DE, Moyer JD, Barbacci EG, Pustilnik LR, Smolarek TA, Davis JA, Vaidya MP, Arnold LD, Doty JL, Iwata KK, Morin MJ. Pollack VA, et al. Among authors: barbacci eg. J Pharmacol Exp Ther. 1999 Nov;291(2):739-48. J Pharmacol Exp Ther. 1999. PMID: 10525095
Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.
Moyer JD, Barbacci EG, Iwata KK, Arnold L, Boman B, Cunningham A, DiOrio C, Doty J, Morin MJ, Moyer MP, Neveu M, Pollack VA, Pustilnik LR, Reynolds MM, Sloan D, Theleman A, Miller P. Moyer JD, et al. Among authors: barbacci eg. Cancer Res. 1997 Nov 1;57(21):4838-48. Cancer Res. 1997. PMID: 9354447 Free article.
The structural basis for the specificity of epidermal growth factor and heregulin binding.
Barbacci EG, Guarino BC, Stroh JG, Singleton DH, Rosnack KJ, Moyer JD, Andrews GC. Barbacci EG, et al. J Biol Chem. 1995 Apr 21;270(16):9585-9. doi: 10.1074/jbc.270.16.9585. J Biol Chem. 1995. PMID: 7721889 Free article.
erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships.
Schnur RC, Corman ML, Gallaschun RJ, Cooper BA, Dee MF, Doty JL, Muzzi ML, DiOrio CI, Barbacci EG, Miller PE, et al. Schnur RC, et al. Among authors: barbacci eg. J Med Chem. 1995 Sep 15;38(19):3813-20. doi: 10.1021/jm00019a011. J Med Chem. 1995. PMID: 7562912
Identification and characterization of an ecto-ATPase activity in rat Sertoli cells.
Barbacci E, Filippini A, De Cesaris P, Ziparo E. Barbacci E, et al. Biochem Biophys Res Commun. 1996 May 15;222(2):273-9. doi: 10.1006/bbrc.1996.0734. Biochem Biophys Res Commun. 1996. PMID: 8670195
TNF-alpha induces surface modifications in mouse Sertoli cells: physiopathological implications.
Ziparo E, Riccioli A, Filippini A, De Cesaris P, Barbacci E. Ziparo E, et al. Ital J Anat Embryol. 1995;100 Suppl 1:553-62. Ital J Anat Embryol. 1995. PMID: 11322336
omega-Conotoxin-sensitive Ca2+ voltage-gated channels modulate protein secretion in cultured rat Sertoli cells.
Taranta A, Morena AR, Barbacci E, D'Agostino A. Taranta A, et al. Mol Cell Endocrinol. 1997 Feb 7;126(2):117-23. doi: 10.1016/s0303-7207(96)03973-1. Mol Cell Endocrinol. 1997. PMID: 9089649
12 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback